ESO - Esophageal adenocarcinoma Back

External References: Wikipedia National Cancer Institute Google Scholar

iCoMut Beta for


Highly significantly mutated genes
TP53
92 patients (65%)
FLG
26 patients (18%)
CDKN2A
9 patients (6%)
Significantly mutated genes
COL5A1
13 patients (9%)
SMARCA4
9 patients (6%)
PIK3CA
5 patients (3%)
IL7R
5 patients (3%)
SMARCB1
3 patients (2%)
Genes near significance
SACS
15 patients (10%)
ERBB4
14 patients (9%)
SMAD4
10 patients (7%)
ARID1A
6 patients (4%)
PIK3R1
6 patients (4%)
CNBD1
5 patients (3%)
KRAS
5 patients (3%)
SETDB1
3 patients (2%)
ERBB2
3 patients (2%)
FAM123B
1 patient (0%)
Click on a gene to see details.

Notes


• Gene name color indicates: known cancer genes | highly compelling novel candidate cancer genes | other candidates

Data details


Mutation list for ESO
Q-Q plots for ESO